Editorials Respond To Court Ruling That FDA Actions On Plan B Contraceptive Tainted By Politics (Medical News Today) Two newspapers published editorials in response to a federal judge's recent order that FDA reconsider age restrictions on nonprescription sales of the emergency contraceptive Plan B and that FDA allow nonprescription sales to women ages 17 and older within 30 days. Summaries appear below.
FDA Requirements For Manufacturing PET Radiopharmaceuticals: Meeting (Medical News Today) SNM and the International Partnership for Critical Markers of Disease (CMOD) are co-hosting an in-depth meeting on Friday, May 1, 2009, examining FDA requirements for manufacturing positron emission tomography (PET) radiopharmaceuticals. The meeting, which takes place at the Natcher Auditorium, National Institutes of Health, Bethesda, Md., is scheduled to begin at 6:10 p.m. and conclude at 9:45 p.
Physio-Control Receives FDA 510(K) Clearance For LIFEPAK(R) 15 Monitor/Defibrillator (Medical News Today) Physio-Control, Inc., a wholly owned subsidiary of Medtronic, Inc., (NYSE: MDT) announced today it has received clearance from the U.S. Food and Drug Administration (FDA) to market the LIFEPAK 15 monitor/defibrillator within the United States. Official notification of the FDA 510(k) Premarket Notification was posted to the FDA website on March 16, 2009, and can be viewed here.